SC: Cheque Dishonour Complaint Can't be Quashed Pre-Trial if Sec 138 NI Act Conditions Met  ||  SC: Personal Hearing Not Required Before Banks Declare Account ‘Fraud’  ||  Supreme Court Faults UCO Bank For Attempt to Stall Employee’s VRS Through Show Cause Notice  ||  SC: PwD Post in Unreserved Category Can be Filled by SC/ST/OBC Candidates With Disabilities  ||  Delhi HC: FSSAI Has No Authority to Regulate Animal Feed  ||  Gauhati HC: Adult Son Pursuing Studies is Not Entitled to Maintenance under Section 125 CrPC  ||  Cal HC Upholds Divorce, Rules False Cases by Wife And 17-Year Separation Constitute Mental Cruelty  ||  Supreme Court: Calling Someone ‘Bastard’ In Heated Exchange Isn’t Obscenity under IPC Section 294  ||  Supreme Court: Even a Single Tainted Public Work Award Violates Article 14  ||  Supreme Court Upholds Lease Cancellation, Denies Relief for Failure to Develop Allotted Land    

Allergan, Intas Pharma Settle Trademark Dispute over Usage of Trademarks Botox and BTX-A - (05 Oct 2015)

US-based Allergan Inc and Gujarat-based Intas Pharmaceuticals have entered into settlement over usage of trademarks Botox and BTX-A. Intas Pharma acknowledged Allergan's exclusive right for registered marks Botox and BTX-A, while the US-based firm accepted Intas' use of the mark BTXA without hyphen.

Tags : ALLERGAN   INTAS PHARMA  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved